131 related articles for article (PubMed ID: 28771133)
1.
Fukuda A; Usui M; Wakao H; Boonla C; Tamura Y
J Med Microbiol; 2017 Aug; 66(8):1202-1206. PubMed ID: 28771133
[No Abstract] [Full Text] [Related]
2. A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against
Ismail N; Zam Z; Hassan SA; Rahman ZA
Malays J Med Sci; 2017 Mar; 24(2):21-27. PubMed ID: 28894400
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of trimethoprim/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt.
Elsheredy A; Elsheikh A; Ghazal A; Shawky S
Acta Microbiol Immunol Hung; 2021 Sep; ():. PubMed ID: 34546967
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of acquired resistance genes in Stenotrophomonas maltophilia].
Song JH; Sung JY; Kwon KC; Park JW; Cho HH; Shin SY; Ko YH; Kim JM; Shin KS; Koo SH
Korean J Lab Med; 2010 Jun; 30(3):295-300. PubMed ID: 20603591
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
7. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
9. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
10. The Activities of Antimicrobials Against
Boonmee P; Nasomsong W; Lorchirachoonkul N; Pungcharoenkijkul S; Juntanawiwat P; Chaemchaeng S; Santimaleeworagun W
Infect Drug Resist; 2023; 16():5173-5184. PubMed ID: 37581163
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
12. Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI.
Kumar S; Bandyopadhyay M; Chatterjee M; Banerjee P; Poddar S; Banerjee D
Adv Biomed Res; 2015; 4():36. PubMed ID: 25789262
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological Trends and Resistance Associated with
Gajdács M; Urbán E
Diseases; 2019 May; 7(2):. PubMed ID: 31159258
[No Abstract] [Full Text] [Related]
14. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Antibiotic Resistance of
Gajdács M; Urbán E
Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
[TBL] [Abstract][Full Text] [Related]
18. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes.
Toleman MA; Bennett PM; Bennett DM; Jones RN; Walsh TR
Emerg Infect Dis; 2007 Apr; 13(4):559-65. PubMed ID: 17553270
[TBL] [Abstract][Full Text] [Related]
19. Genotypic Diversity, Antibiotic Resistance, and Virulence Phenotypes of
Yinsai O; Deeudom M; Duangsonk K
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830320
[No Abstract] [Full Text] [Related]
20. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]